Нерешенные вопросы в лечении тромбоэмболии легочной артерии

1. Котельников М.В. ТЭЛА: Современные подходы к дечению: Метод, рекомендации / Под ред. Л.Б. Лазебника. М.: Издатель Е.Разумова; 2003.

2. Task Force Report. Guidelines on diagnosis and management of acute pulmonary embolism. European Society of Cardiology. Eur. Heart J. 2000; 21: 1301-1336.

3. The Sixth (2000) ACCP guidelines or antithrombotic therapy for prevention and treatment of thrombosis. Chest 2001; 119 (suppl. 1): 1-370. -

4. Rodger M., Wells P.S. Diagnosis of pulmonary embolism. Thromb. Res. 2001; 103: 225-238.

5. Gallus A., Jackaman J., Tillett J. et al. Safety and efficacy of warfarin started early after submassive venous thrombosis or pulmonary embolism. Lancet 1986; 2: 1293-1296. [Medline] Цит.по: Guide to anticoagulant therapy: Heparin. A statement for healthcare professionals from the American Heart Association. Circulation 2001; 103: 2994.

6. Hull R.D., Raskob G.E., Rosenbloom D. et al. Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis. N. Engl. J. Med. 1990; 322: 1260-1264.

7. Shulman S., Rhedin A.S., Lindmarker P. et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. N. Engl. J. Med. 1995* 332: 1661-1665.

8. Agnelli G., Prandoni P., Santamaria M.G. et al. Three month versus one year of oral anticoagulant therapy for idiopathic deep vein throbosis. N.Engl. J. Med. 2001; 345 (3): 165-169.

9. Agnell G., Bcattini C., Kirschtein T. Thrombolysis versus heparin in the treatment of pulmonary embolism: a clinical outcome based meta-analysis. Arch. Intern. Med. 2002; 162: 2537-2541.

10. Boumanameaux H., Vermylen J., Collen D. Thrombolytic treatment with recombinant tissue-type plasminogen activator in patient with pulmonary embolism. Ann. Intern. Med. 1985; 103: 64-66.

11. Goldhaber S.Z., Haire W.D., Feldstein M.L. et al. Alteplase versus heparin in acute pulmonary embolism: randomized trial assessing right ventricular function and pulmonary perfusion. Lancet 1993; 341: 507-511.

12. Konstantinides S., Geibel A., Heusel G. et al. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N. Engl. J. Med. 2002; 3471143 -1150.

13. Jerjes-Sanchez C., Ramirez-Rivera A., Garcia M. de L. et al. Streptokinase and heparine versus heparine alone in massive pulmonary embolism. A randomized clinical trial. J. Thromb. Thrombolys. 1995; 2: 227-229.

14. Thomas M.D., Chauhan A., More R.S. Pulmonary embolism — an update on thrombolytic therapy. Quart. J. Med. 2000; 93: 261-267.

15. Streiff M.B. Vena caval filters: a comprehensive review. Blood 2000; 95: 3669-3677.

16. Hervy Decousus et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. N. Engl. J. Med. 1998; 338: 409-416.

17. Verhaeghe R., Agnelli G., Becattini C. et al. Therapeutic aspects of pulmonary embolism. In: Demedts M. et al., eds. Pulmonary vascular pathology: a clinical update. European Respiratory Society; 2004; vol. 9, monograph. 27.

18. Pacouret G. Alison D., Pottier J.M. et al. Free-floating thrombus and embolic risk in patients with angiographically confirmed proximal deep vein thrombosis: a prospective study. Arch. Intern. Med. 1997; 157: 305-308.

19. Meyer G., Tamisier D., Sors H. et al. Pulmonary embolectomy: a 20 years experience at one center. Ann. Thorac. Surg. 1991; 51:232-236.

20. Robinson R.J., Fehrenbacher J., Brown J.W. et al. Emergent pulmonary embolectomy: the treatment for massive pulmonary embolus. Ann. Thorac. Surg. 1986; 42: 52-55.

21. Carcone B., Femes J.M., Carcopino J.M. et al. Worsening of proximal thrombosis after insertion of a temporary caval filter (3 cases). Rev. Med. Interne 1995; 16 (5): 351-353.

22. Lorch H., Welger D., Wagner V. et al. Current practice of temporary vena cava filter insertion: a multicenter registry. J. Vase. Interv. Radiol. 2000; 11 (1): 83-88. Comment in: J. Vase. Interv. Radiol. 2000; 11 (10): 1363-1364.

23. Vos L.D., Tielbeek A.V., Bom E.P. et al. The Gunther temporary inferior vena cava filter for short-term protection against pulmonary embolism. Cardiovasc. Intervent. Radiol. 1997; 20 (2): 91-97.